These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24390454)

  • 1. Isolated bilateral uveitis in child with hypereosinophilic syndrome.
    Ramzan M; Chopra Y; Grover AK; Yadav SP
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e465-7. PubMed ID: 24390454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficiency of imatinib in polyserositis revealing a FIP1L1-PDGFRA-negative hypereosinophilic syndrome].
    Green L; Kahn JE; Dufour JF; Le Scanff J; Charhon A; Broussolle C; Sève P
    Rev Med Interne; 2010 Apr; 31(4):305-8. PubMed ID: 20167399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of myeloid neoplasm associated with eosinophilia and KIAA1509-PDGFRβ responsive to combination treatment with imatinib mesylate and prednisolone.
    Wang JR; Yen CC; Gau JP; Hsiao LT; Liu CY; Pai JT; Tzeng CH; Teng HW
    J Clin Pharm Ther; 2010 Dec; 35(6):733-6. PubMed ID: 21054467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloproliferative hypereosinophilic syndrome presenting as cardiac failure and response to imatinib.
    Desai N; Morkhandikar S; Sahay R; Jijina F; Patil P
    Am J Ther; 2014; 21(2):e35-7. PubMed ID: 24603276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
    Hofmann SC; Technau K; Müller AM; Lübbert M; Bruckner-Tuderman L
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S68-72. PubMed ID: 17097375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and therapeutic management in patients with hypereosinophilic syndromes.
    Helbig G; Kyrcz-Krzemień S
    Pol Arch Med Wewn; 2011; 121(1-2):44-52. PubMed ID: 21346698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent cough: an unusual cause. Idiopathic hypereosinophilic syndrome (HES).
    Barker B; Moudgil H; Slocombe G; Srinivasan K
    Thorax; 2010 Nov; 65(11):1009, 1024. PubMed ID: 20965936
    [No Abstract]   [Full Text] [Related]  

  • 8. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
    Moles MP; Landry J; Roche-Lestienne C; Godon A; Schmidt-Tanguy A; Gardembas M; Le Clech C; Verret JL; Zandecki M; Blanchet O
    Ann Biol Clin (Paris); 2005; 63(3):317-22. PubMed ID: 15951264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib mesylate for the treatment of hypereosinophilic syndromes.
    Antoniu SA
    Curr Opin Investig Drugs; 2006 Nov; 7(11):980-4. PubMed ID: 17117585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of ulcerative colitis associated with hypereosinophilic syndrome/chronic eosinophilic leukemia.
    Awano N; Ryu T; Yoshimura N; Takazoe M; Kitamura S; Tanaka M
    Intern Med; 2011; 50(16):1741-5. PubMed ID: 21841337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loeffler endocarditis in a pediatric patient.
    Keivanidou A; Giannopoulos A; Papageorgiou T; Hatzipantelis E; Pana Z; Athanasiadou F
    Pediatr Hematol Oncol; 2014 May; 31(4):375-9. PubMed ID: 23802753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
    Garg A; Duggal L; Aggarwal S; Jain N
    J Assoc Physicians India; 2006 Nov; 54():883-6. PubMed ID: 17249259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinib.
    Garcia-Alvarez A; Sitges M; Garcia-Albeniz X; Sionis A; Loma-Osorio P; Bosch X
    Int J Cardiol; 2010 Mar; 139(2):e29-31. PubMed ID: 19056137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome.
    Cortes J; Ault P; Koller C; Thomas D; Ferrajoli A; Wierda W; Rios MB; Letvak L; Kaled ES; Kantarjian H
    Blood; 2003 Jun; 101(12):4714-6. PubMed ID: 12595304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate treatment in two patients with idiopathic hypereosinophilic syndrome.
    Payne SM; Kovacs MJ
    Ann Pharmacother; 2004; 38(7-8):1215-8. PubMed ID: 15187212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.
    Wang LN; Pan Q; Fu JF; Shi JY; Jin J; Li JM; Hu J; Zhao WL; Chen Z; Chen SJ
    Chin Med J (Engl); 2008 May; 121(10):867-73. PubMed ID: 18706197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypereosinophilic syndrome with imatinib mesilate.
    Gleich GJ; Leiferman KM; Pardanani A; Tefferi A; Butterfield JH
    Lancet; 2002 May; 359(9317):1577-8. PubMed ID: 12047970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Images in cardiology: Hypereosinophilic syndrome and effect of imatinib mesylate.
    Jacob S; Kovacs RJ
    Clin Cardiol; 2005 Apr; 28(4):188. PubMed ID: 15869052
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypereosinophilic syndrome--recent developments in diagnosis and treatment].
    Hellmich B; Holl-Ulrich K; Gross WL
    Dtsch Med Wochenschr; 2007 Sep; 132(37):1892-6. PubMed ID: 17823882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia.
    Kalac M; Quintás-Cardama A; Vrhovac R; Kantarjian H; Verstovsek S
    Cancer; 2007 Sep; 110(5):955-64. PubMed ID: 17654661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.